A global biotechnology innovator focused on improving treatment outcomes and patient access
BeiGene is a fully-integrated biotechnology company co-founded in 2010 by John Oyler, an American entrepreneur, and Dr. Xiaodong Wang, one of the youngest ever U.S. Academy of Science members and
Director of China’s National Institute of Biological Sciences (NIBS) in Beijing. The two set out to build a unique company that was globally focused from its inception. BeiGene (NASDAQ: BGNE; HKEX 06160) focuses on developing novel therapies where there is global unmet need.